Citadel Advisors - RENALYTIX PLC ownership

RENALYTIX PLC's ticker is RNLX and the CUSIP is 75973T101. A total of 28 filers reported holding RENALYTIX PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of RENALYTIX PLC
ValueSharesWeighting
Q3 2023$18,560
-64.9%
11,600
-35.9%
0.00%
Q2 2023$52,852
-20.6%
18,100
-34.2%
0.00%
Q1 2023$66,596
+182.6%
27,519
+118.4%
0.00%
Q4 2022$23,562
-78.0%
12,600
-85.0%
0.00%
Q3 2022$107,000
-56.0%
83,869
-15.5%
0.00%
Q2 2022$243,000
-71.8%
99,245
-20.3%
0.00%
Q1 2022$861,000
-67.6%
124,473
-25.5%
0.00%
Q4 2021$2,657,000
+175.3%
167,095
+247.0%
0.00%
Q3 2021$965,000
-33.6%
48,150
+2.2%
0.00%
Q2 2021$1,454,000
+238.9%
47,109
+182.1%
0.00%
Q1 2021$429,000
+146.6%
16,700
+53.1%
0.00%
Q4 2020$174,00010,9050.00%
Other shareholders
RENALYTIX PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Tejara Capital Ltd 441,805$1,290,0710.64%
PINNACLE ASSOCIATES LTD 839,322$2,450,8200.04%
GILDER GAGNON HOWE & CO LLC 1,027,746$3,001,0170.04%
Retirement Group, LLC 10,000$29,2000.01%
Pentwater Capital Management LP 565,000$1,649,8000.01%
North Star Investment Management Corp. 31,000$90,5200.01%
StoneX Group Inc. 13,343$390.01%
Granahan Investment Management 18,747$54,7410.00%
Corient Private Wealth LLC 225,724$659,1140.00%
LAZARD ASSET MANAGEMENT LLC 143,930$4200.00%
View complete list of RENALYTIX PLC shareholders